碧迪医疗(Becton Dickinson) BDX

Mr. Thomas E. Polen, Jr, BD's Chief Executive Officer since 2020, and appointed Chairman in 2021. Has served as BD's President since April 2017, and also served as BD's Chief Operating Officer from October 2018 to January 2020. Served as Executive Vice President and President of BD's Medical segment prior to becoming President. Public directorships-Walgreens Boots Alliance.

Mr. Michael Feld, Executive Vice President and President, Life Sciences since August 2024; President of Hach (Veralto Corporation) from September 2023 to August 2024; Senior Vice President and General Manager of Danaher Corporation from June 2022 to September 2023; and President of Mammotome (Danaher Corporation) from January 2019 to September 2022.

Mr. R. Andrew Eckert, Serves as a Senior Advisor to Permira, a global private equity firm, since 2023. Serves as Board Chairman of Lytx, Inc., a technology company that designs, manufactures and sells video telematics products, since July 2025, after joining the Board of Directors in December 2024, and served as Interim Chief Executive Officer, from December 2024 to June 2025. Served as Chief Executive Officer of Zelis Inc., a provider of healthcare cost management and payments solutions, from 2020 to 2021. Previously served as President and Chief Executive Officer of Acelity L.P. Inc., a global wound care company, from 2017 until the sale of the company in October 2019. Previously served as the Chief Executive Officer of Valence Health, Inc., a healthcare information technology and services company, from 2015 until the sale of the company in October 2016. Previously served as Chief Executive Officer of TriZetto Corporation, a payer technology solutions firm, until the sale of the company in November 2014. Public directorships: Maravai Lifesciences Holdings, Inc. (Board Chairman). Former public directorships (last 5 years): Fortrea Holdings Inc. (Lead Director); Varian Medical Systems, Inc.

Mr. Timothy M. Ring, Served as C. R. Bard's Chairman and Chief Executive Officer from 2003 until 2017, when it was acquired by BD. Co-founder of TEAMFund, Inc., an impact fund focused on delivering medical technology to sub-Saharan Africa and India. Public directorships- Quest Diagnostics Incorporated (Lead Director).

William M. Brown, Chairman and Chief Executive Officer, 3M Company. Professional background: Chairman of 3M Company, since March 2025 and Chief Executive Officer, since May 2024. Served as Executive Chair of L3Harris Technologies, from June 2021 to June 2022, having served as Chairman and Chief Executive Officer, from July 2019 to June 2021. Previously served as Chair, President and Chief Executive Officer of Harris Corporation until its 2019 merger with L3 Technologies. Mr. Brown joined Harris Corporation in November 2011 as President and Chief Executive Officer and was appointed Chair in April 2014. Prior to that, Mr. Brown served in a variety of leadership roles over 14 years at United Technologies Corporation (UTC), including Senior Vice President of Corporate Strategy and Development and President of UTC, Fire & Safety. Public directorships: 3M Company (Chairman and CEO). Former public directorships (last 5 years): Celanese Corporation (Lead Director); L3Harris Technologies, Inc. (Executive Chair).

Mr. Gregory J. Hayes, Former Executive Chairman and Chief Executive Officer, RTX Corporation. Professional background: Serves as a Special Advisor to the Chief Executive Officer of RTX Corporation, an aerospace and defense company, from May 2025 and has agreed to serve in this capacity until January 2026. Served as Executive Chairman and Chief Executive Officer of RTX Corporation, from March 2023 to April 2025. Previously served as Chairman, President and Chief Executive Officer of Raytheon Technologies Corporation, from June 2021 to February 2023, and as President, Chief Executive Officer and Board of Directors member, from April 2020 to June 2021. Previously served as Board Chairman of United Technologies Corporation (UTC), a former conglomerate that owned and operated various aerospace, elevator and climate-control businesses, from 2016 to 2020, Chief Executive Officer, from 2014 to 2016, and Chief Financial Officer, from 2008 to 2014. Following the April 2020 spin-off of the non-aerospace businesses to its shareholders, UTC merged into Raytheon Technologies Corporation and the combined company was subsequently renamed RTX Corporation. Public directorships: Phillips 66 Company. Former public directorships (last 5 years): RTX Corporation.

David Shan, Executive Vice President and Chief Integrated Supply Chain Officer since January 2023; Executive Vice President and Chief Quality Officer from March 2020 to August 2023; Senior Vice President, Global Supply Chain from May 2018 to August 2020; Senior Vice President, Worldwide Operations Devices from December 2017 to May 2018.

Mr. Bilal Muhsin, Executive Vice President and President of Connected Care Segment since July 2025; Chief Operating Officer of Masimo Corporation from April 2019 to July 2025.

Roland Goette, Executive Vice President and President, EMEA since May 2017; and President, Europe from October 2014 to May 2017.

Mr. Antoine C. Ezell, Executive Vice President, President of the Americas and Chief Marketing Officer since October 2020; Executive Vice President and Chief Marketing Officer from January 2020 to October 2020; Vice President, Connected Care and Insulins, Eli Lilly and Company from January 2019 to January 2020; and prior thereto, Vice President, Enterprise Capabilities and Solutions, Eli Lilly; Chief Marketing Officer, Elanco Animal Health; and Chief Customer Officer, Eli Lilly.

Ms. Shana Carol Neal, Executive Vice President and Chief People Officer since April 2022; Chief Human Resources Officer of Owens & Minor from April 2018 to March 2022; Senior Vice President, Human Resources of BD from January 2017 to March 2018.

On January 9, 2025, the Board of Directors of Becton, Dickinson and Company appointed Pamela L. Spikner as Senior Vice President, Chief Accounting Officer and Controller, effective January 20, 2025. Prior to joining the Company, Ms. Spikner, age 48, served as Chief Accounting Officer of R1 RCM since July 2021. Ms. Spikner also previously was Assistant Corporate Controller of Hill-Rom Holdings, Inc., a medical technology provider, from July 2019 to July 2021. Ms. Spikner held various accounting leadership roles at Exelon Corporation, a utility services holding company, from September 2007 to July 2019.

Mr. Pavan Kumar Mocherla, Executive Vice President and President, Greater Asia since July 2022; Country General Manager, South Asia/Managing Director from December 2017 to June 2022; Vice President of Strategic Innovation for Greater Asia from August 2017 to December 2017.

On November 17, 2025, Jacqueline Wright was elected to the Board of Directors of Becton, Dickinson and Company, effective December 1, 2025.

On November 17, 2025, Robert L. Huffines was elected to the Board of Directors of Becton, Dickinson and Company, effective December 1, 2025.

Mr. Roque, age 43, has served as the Senior Vice President of Finance, Business Units and Corporate Financial Planning & Analysis at the Company since September 2024. In this role, he oversees the financial operations across all BD business units and leads the central capability for segment strategic support and financial planning and analysis. Prior to his current role, he held key positions at BD, including Vice President and CFO of BD Medical Segment from July 2021 through November 2024 and Vice President of Finance for Medication Management Solutions from January 2019 through August 2021. Mr. Roque brings more than 20 years of global finance and leadership experience. Vitor Roque, Senior Vice President of Finance, Business Units and Corporate Financial Planning & Analysis, has been appointed by the Company's Board of Directors to act as the Company's interim Chief Financial Officer, effective December 5, 2025.

Michelle Quinn, Executive Vice President and General Counsel since April 2023; Senior Vice President, Deputy General Counsel and Chief Ethics and Compliance Officer from February 2022 to April 2023; Senior Vice President, Chief Ethics & Compliance Officer, Chief Regulatory Counsel from May 2019 to January 2023; Senior Vice President, Chief Compliance Officer from February 2019 to May 2019; Vice President, General Counsel of North America of Sandoz Inc. from January 2017 to January 2019.